Kintara Therapeutics, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
#1 News Source For Stock & Crypto Traders
1) Sign Up for our Free Email Newsletter:
dexwirenews.com/sign-up/
2) Follow Us on Telegram @ t.me/DEXWireNews
3) Subscribe to our YouTube Channel @ youtube.com/@DEXWireNews
1) Sign Up for our Free Email Newsletter:
dexwirenews.com/sign-up/
2) Follow Us on Telegram @ t.me/DEXWireNews
3) Subscribe to our YouTube Channel @ youtube.com/@DEXWireNews